The U.K.’s decision to delay giving people the second dose of a coronavirus vaccine is proving controversial, with experts, advisors and the vaccine producers all weighing in on the strategy.
Britain was among the first countries in the world to kick off a mass vaccination campaign against the coronavirus, after approving the Covid-19 vaccine developed by Pfizer and BioNTech at the start of December. On Monday this week, it started rolling out the University of Oxford and AstraZeneca’s vaccine, having approved it for use just ahead of the new year.
As both vaccines require two doses per person, the U.K. government said initially that a second dose would be given either three or four weeks after the first dose, depending on which vaccine was being given and in line with the dosing regimens tested in clinical trials. Read more…..
Chart of the Day
Warren Buffett said “When I see memos from Howard Marks in my mail, they’re the first thing I open and read.” Howard is the Co-Chairman of Oaktree Capital Management. He is known in the investment community for his “Oaktree memos” to clients which detail investment strategies and insight into the economy.